In this blog, I review six randomised, controlled trials comparing N-Acetylcysteine (NAC) versus placebo for the treatment of OCD. NAC is a glutamate regulator and has good tolerability. Four trials tested it in adults, and two tested it in children.

In this blog I discuss a recent publication (Davis et al, 2020) which looked at a novel treatment for depression: Psilocybin. I review the study, look at the outcomes, and consider what the implications might be for treatment.